HEMISPHERX BIO

HEB AMEX
4.060
-0.070
-1.69%
After Hours: 3.980 -0.08 -1.97% 17:55 07/16 EDT
Open
4.100
Prev Close
4.130
High
4.150
Low
3.900
Volume
56.46K
Avg Vol (3M)
193.55K
52 Week High
14.81
52 Week Low
3.620
% Turnover
2.57%
Market Cap
8.93M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers HEMISPHERX BIO HEB stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Hemispherx Biopharma, Inc. (Hemispherx) is a specialty pharmaceutical company. The Company is engaged in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. The Company's segment is engaged in research and development activities related to Ampligen and other drugs under development, and sales and marketing of Alferon. The Company's products include Alferon N Injection and Ampligen. Alferon N Injection is approved for the use in intralesional treatment of refractory or recurring external genital warts in patients of over 18 years of age. Ampligen is a drug undergoing clinical development for the treatment of Chronic Fatigue Syndrome (CFS). Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) is a low-dose, oral liquid formulation of natural alpha interferon. Alferon LDO is a liquid natural interferon for oral administration.
MORE >

Recently

Name
Price
%Change